Market revenue in 2023 | USD 1,720.7 million |
Market revenue in 2030 | USD 3,126.7 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 85.54% in 2023. Horizon Databook has segmented the Middle East & Africa precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
There is availability of several million genomes in global public databases, however, there is also a critical lack of high-quality single reference genomes for the Middle East and North Africa (MENA) region, including individual countries in it. This gap highlights an urgent need for attention.
Population genomics initiatives are underway in six MENA countries, including Saudi Arabia, Qatar, Egypt, the UAE, Bahrain, and Iran. These initiatives are making significant progress in establishing high-throughput and high-quality Population Genomic Projects (PGPs) in the region.
The increasing activity in population scale genomics programs is expected to lead to the publication of research articles in scientific journals, thereby increasing the representation of Middle Eastern genomes in public genetic databases. Current and future population-scale genomics projects should consider the challenges highlighted in this review to ensure ethical, regulated, and efficient conduct.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account